34 reports

  • 11.3 NOVARTIS AG
  • Joint Venture
  • Ophthalmic Solution
  • World
  • Forecast
  • Market Size
  • Galderma S.A.
  • Clinical Trial profile. 41 Trial Title
  • Clinical Trial profile. 60 Trial Title
  • Ophthalmic Solution
  • Respiratory Treatment
  • World
  • Product Initiative
  • Alcon, Inc.
  • Strengths
  • Scope of the report
  • Anti-Infective
  • Ophthalmic Solution
  • Akorn, Inc.
  • Alcon, Inc.
  • Allergan plc
  • OCT 03, 2013: LUPIN LAUNCHES GENERIC ZYMAXID OPHTHALMIC SOLUTION IN THE US
  • JUL 01, 2013: LUPIN GETS FDA TENTATIVE APPROVAL FOR GATIFLOXACIN EYE DROPS
  • Eye Disease
  • Ophthalmic Solution
  • United States
  • Litigation And Patent
  • InSite Vision Incorporated
  • OCT 03, 2013: LUPIN LAUNCHES GENERIC ZYMAXID OPHTHALMIC SOLUTION IN THE US
  • JUL 01, 2013: LUPIN GETS FDA TENTATIVE APPROVAL FOR GATIFLOXACIN EYE DROPS
  • Eye Disease
  • Ophthalmic Solution
  • United States
  • Litigation And Patent
  • InSite Vision Incorporated
  • Clinical Trial profile. 33 Trial Title
  • Clinical Trial profile. 57 Trial Title
  • Ophthalmic Solution
  • Ophthalmology
  • OTC
  • World
  • Product Initiative
  • Clinical Trial profile. 465
  • Clinical Trial profile. 102
  • Allergy Drug
  • Clinical Trial
  • Ophthalmic Solution
  • World
  • Alcon, Inc.
  • Clinical Trial profile. 27 Trial Title
  • Clinical Trial profile. 175 Trial Title
  • Allergy Drug
  • Ophthalmic Solution
  • Therapy
  • World
  • Alcon, Inc.

Ophthalmic Solution Versus Vigamox in the Conjunctiva of Healthy Volunteers Following a Single Ocular Administration Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers GDCT## NCT##, ##-##; P## Ophthalmology Bacterial Conjunctiviti

  • Eye Disease
  • Healthcare
  • Ophthalmic Solution
  • World
  • Product Initiative
  • Weakness - Safety Concerns

In April, the company received the US FDA approval for its New Drug Application (NDA) for Prolensa (bromfenac ophthalmic solution) ##. ##% nonsteroidal anti-inflammatory ophthalmic solution.

  • Eye Disease
  • Ophthalmic Solution
  • Ophthalmology
  • United States
  • Bausch & Lomb Incorporated
  • JUL 22, 2016: VALEANT PHARMACEUTICALS RECEIVES COMPLETE RESPONSE LETTER FROM THE FDA
  • BAUSCH & LOMB ENTERS INTO DISTRIBUTION AGREEMENT WITH MICRO LABS
  • Eye Disease
  • Ophthalmic Solution
  • Ophthalmology
  • United States
  • Bausch & Lomb Incorporated
  • KEY M&A
  • Vendor landscape
  • Ophthalmic Solution
  • Akorn, Inc.
  • Alcon, Inc.
  • Allergan plc
  • Bausch & Lomb Incorporated
  • NICOX SA - LOCATIONS AND SUBSIDIARIES
  • HEAD OFFICE

It provides clinical developmental solutions in the areas of ophthalmic such as allergy, allergic rhinitis, dry eye, retina, anti-infective, antiinflammatory, glaucoma, drug delivery and devices.

  • Ophthalmic Solution
  • United States
  • Company
  • M&A
  • NicOx S.A.

The company has started providing ophthalmic solutions like Zeiss Ophthalmic Data Management Solution, Zeiss Toric Solution & Zeiss Refractive Laser Solution.

  • Ophthalmic Solution
  • Abbott Medical Optics, Inc.
  • Alcon, Inc.
  • Carl Zeiss Meditec AG
  • Essilor group
  • Implementing inorganic growth strategies Advancing its pipeline through increased investment...
  • Vendor landscape

It is a polyvinyl alcohol ophthalmic solution, which consists of ##. ##% ocular lubricant sterile solution.

  • Ophthalmic Solution
  • Akorn, Inc.
  • Alcon, Inc.
  • Allergan plc
  • Bausch & Lomb Incorporated
  • 6.2.3 MUCOSTA OPHTHALMIC SOLUTION (REBAMIPIDE)
  • PRODUCT PROFILE - LIFITEGRAST
  • Ophthalmic Solution
  • Allergan plc
  • Herantis Pharma Plc
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • CETIRIZINE HYDROCHLORIDE - DRUG PROFILE
  • Regulatory Details
  • Ophthalmic Solution
  • OTC
  • Therapy
  • United States
  • Product Initiative

Multipurpose solutions and one step peroxide solutions are covered under this segment.

  • Ophthalmic Solution
  • Pharmaceutical
  • North America
  • Forecast
  • Valeant Pharmaceuticals International, Inc.
  • CETIRIZINE HYDROCHLORIDE - DRUG PROFILE

Patent (No. ##, ##, ##) covering AC-## Cetirizine Ophthalmic Compositions.

  • Ophthalmic Solution
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

Ophthalmic Solution in Providing Symptomatic Relief in Subjects with Allergic Conjunctivitis A Clinical Trial to Assess the Efficacy and Safety of LP##-## Versus Olopatadine Ophthalmic Solution in Subjects with Allergic Conjunctivitis GDCT## CTRI/ 2011&#

  • Allergy Drug
  • Ophthalmic Solution
  • World
  • Product Initiative
  • Circassia Pharmaceuticals plc
  • 5.2.3 Mucosta ophthalmic solution (rebamipide)
  • Product Profile - Lifitegrast
  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • 5.2.3 Mucosta ophthalmic solution (rebamipide)
  • Product Profile - Lifitegrast
  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • 5.2.3 Mucosta ophthalmic solution (rebamipide)
  • Product Profile - Tavilermide
  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • 5.2.3 Mucosta ophthalmic solution (rebamipide)
  • Product Profile - Mucosta
  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

Ophthalmic Solution ISOPTO Carpine Ophthalmic Solution ISOPTO Homatropine Ophthalmic Solution MAXIDEX Ophthalmic Suspension Ophthalmic Product/ Solution Contact Lenses Category S ALOMIDE Ophthalmic

  • Ophthalmic Solution
  • Market Size
  • Johnson & Johnson
  • Luxottica Group
  • Novartis AG
  • 5.2.3 Mucosta ophthalmic solution (rebamipide)
  • Product Profile - Lifitegrast
  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • TRENDS

ophthalmic solution in concentrations of ##. ##mg/ ml, ##. ##mg/ ml (##. ##%), ##mg/ ml and ##. ##mg/ ml, benefiting brands such as Luz Zul and Nazil Ofteno.

  • Ophthalmic Solution
  • OTC
  • Colombia
  • Demand

The company offers near vision solutions and develops ophthalmic medical devices.

  • Eye Disease
  • Ophthalmic Solution
  • North America
  • United States
  • Alcon, Inc.

SOLUTION OF GRASS POLLEN ALLERGEN IN CHILDREN WITH CLINICALLY RELEVANT GRASS POLLEN SENSITIVITY IN COMPARISON TO A STANDARD TREATMENT WITH ADD ON PLACEBO MULTICENTER TRIAL OF SUBLINGUAL IMMUNOTHERAPY WITH A SOLUTION OF GRASS POLLEN ALLERGEN EXTRACT IN CHILDREN GDCT## NCT##

  • Allergy Drug
  • Ophthalmic Solution
  • OTC
  • World
  • Product Initiative
  • Allergan Inc Business Segmentation by Revenue in %, 2013
  • 8.3 Allergan Inc.
  • Ophthalmic Solution
  • Alcon, Inc.
  • Allergan plc
  • Bausch & Lomb Incorporated
  • Merck & Co., Inc.